Michael D. Robek

3.4k total citations
55 papers, 2.8k citations indexed

About

Michael D. Robek is a scholar working on Epidemiology, Immunology and Hepatology. According to data from OpenAlex, Michael D. Robek has authored 55 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 30 papers in Immunology and 16 papers in Hepatology. Recurrent topics in Michael D. Robek's work include Hepatitis B Virus Studies (28 papers), Hepatitis C virus research (15 papers) and Viral Infections and Outbreaks Research (11 papers). Michael D. Robek is often cited by papers focused on Hepatitis B Virus Studies (28 papers), Hepatitis C virus research (15 papers) and Viral Infections and Outbreaks Research (11 papers). Michael D. Robek collaborates with scholars based in United States, China and Israel. Michael D. Robek's co-authors include Francis V. Chisari, Lee Ratner, Bryan Boyd, Masanori Isogawa, Yoshihiro Furuichi, Steven H. Kleinstein, Siyuan Ding, Christopher R. Bolen, John K. Rose and Stefan Wieland and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Gastroenterology.

In The Last Decade

Michael D. Robek

54 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael D. Robek United States 29 1.5k 1.4k 936 463 398 55 2.8k
Eileen Foy United States 8 2.9k 2.0× 1.9k 1.4× 2.1k 2.3× 695 1.5× 82 0.2× 9 4.6k
Simon P. Fletcher United States 27 692 0.5× 1.8k 1.4× 1.5k 1.6× 398 0.9× 113 0.3× 59 3.0k
Marco Binder Germany 24 2.6k 1.8× 1.2k 0.9× 1.1k 1.1× 696 1.5× 58 0.1× 56 3.9k
Rohit K. Jangra United States 22 485 0.3× 395 0.3× 349 0.4× 877 1.9× 131 0.3× 43 2.2k
Yan‐Jin Zhang United States 31 452 0.3× 798 0.6× 585 0.6× 1.5k 3.2× 201 0.5× 100 3.1k
Meike Dittmann United States 15 1.8k 1.2× 859 0.6× 123 0.1× 1.2k 2.5× 101 0.3× 26 3.4k
Mary Y. Murphy United States 4 1.3k 0.9× 456 0.3× 224 0.2× 599 1.3× 72 0.2× 7 2.3k
Franziska Lechner Switzerland 20 2.5k 1.7× 1.4k 1.0× 1.5k 1.6× 370 0.8× 60 0.2× 27 3.9k
Hiba El Hajj Lebanon 28 703 0.5× 1.1k 0.8× 50 0.1× 241 0.5× 368 0.9× 75 2.8k
Yinyan Sun China 18 291 0.2× 1.9k 1.4× 1.4k 1.5× 496 1.1× 33 0.1× 28 2.6k

Countries citing papers authored by Michael D. Robek

Since Specialization
Citations

This map shows the geographic impact of Michael D. Robek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Robek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Robek more than expected).

Fields of papers citing papers by Michael D. Robek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Robek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Robek. The network helps show where Michael D. Robek may publish in the future.

Co-authorship network of co-authors of Michael D. Robek

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Robek. A scholar is included among the top collaborators of Michael D. Robek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Robek. Michael D. Robek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Robek, Michael D., et al.. (2024). CD40 stimulation activates CD8+ T cells and controls HBV in CD4-depleted mice. JHEP Reports. 6(9). 101121–101121. 1 indexed citations
2.
Schmidt, Sarah, Stéphane Daffis, Adrian Tomkinson, et al.. (2023). Alternating Arenavirus Vector Immunization Generates Robust Polyfunctional Genotype Cross-Reactive Hepatitis B Virus–Specific CD8 T-Cell Responses and High Anti–Hepatitis B Surface Antigen Titers. The Journal of Infectious Diseases. 229(4). 1077–1087. 4 indexed citations
3.
Chiale, Carolina, et al.. (2021). Virus-based vaccine vectors with distinct replication mechanisms differentially infect and activate dendritic cells. npj Vaccines. 6(1). 138–138. 4 indexed citations
4.
Balnis, Joseph, Andy Madrid, Kirk J. Hogan, et al.. (2021). Blood DNA methylation and COVID-19 outcomes. Clinical Epigenetics. 13(1). 118–118. 68 indexed citations
5.
Stellrecht, Kathleen A., et al.. (2021). Lack of active SARS-CoV-2 virus in a subset of PCR-positive COVID-19 congregate care patients. Journal of Clinical Virology. 141. 104879–104879. 4 indexed citations
6.
Rabinowitz, Jesse C., et al.. (2021). xCT/SLC7A11 antiporter function inhibits HIV-1 infection. Virology. 556. 149–160. 12 indexed citations
7.
Chiale, Carolina, et al.. (2019). Mechanisms of Innate Immune Activation by a Hybrid Alphavirus–Rhabdovirus Vaccine Platform. Journal of Interferon & Cytokine Research. 40(2). 92–105. 5 indexed citations
8.
Yarovinsky, Timur O., Stephen W. Mason, Maria Haslip, et al.. (2019). Virus-like Vesicles Expressing Multiple Antigens for Immunotherapy of Chronic Hepatitis B. iScience. 21. 391–402. 11 indexed citations
9.
10.
Pol, Anthony N. van den, Siyuan Ding, & Michael D. Robek. (2014). Long-Distance Interferon Signaling within the Brain Blocks Virus Spread. Journal of Virology. 88(7). 3695–3704. 48 indexed citations
11.
Ding, Siyuan, William Khoury-Hanold, Akiko Iwasaki, & Michael D. Robek. (2014). Epigenetic Reprogramming of the Type III Interferon Response Potentiates Antiviral Activity and Suppresses Tumor Growth. PLoS Biology. 12(1). e1001758–e1001758. 42 indexed citations
12.
Garcia, Mayra L., Tracy Reynolds, Walther Mothes, & Michael D. Robek. (2013). Functional Characterization of the Putative Hepatitis B Virus Core Protein Late Domain Using Retrovirus Chimeras. PLoS ONE. 8(8). e72845–e72845. 15 indexed citations
13.
Bolen, Christopher R., Siyuan Ding, Michael D. Robek, & Steven H. Kleinstein. (2013). Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression. Hepatology. 59(4). 1262–1272. 153 indexed citations
14.
Bolen, Christopher R., Michael D. Robek, Leonid Brodsky, et al.. (2012). The Blood Transcriptional Signature of Chronic Hepatitis C Virus Is Consistent with an Ongoing Interferon-Mediated Antiviral Response. Journal of Interferon & Cytokine Research. 33(1). 15–23. 35 indexed citations
15.
Robek, Michael D., et al.. (2010). Interferon-λ in the Immune Response to Hepatitis B Virus and Hepatitis C Virus. Journal of Interferon & Cytokine Research. 30(8). 585–590. 35 indexed citations
16.
17.
Bandi, Prasanthi, et al.. (2009). Inhibition of Type III Interferon Activity by Orthopoxvirus Immunomodulatory Proteins. Journal of Interferon & Cytokine Research. 30(3). 123–134. 23 indexed citations
18.
Kleinstein, Steven H., et al.. (2008). Interleukin-29 Functions Cooperatively with Interferon to Induce Antiviral Gene Expression and Inhibit Hepatitis C Virus Replication. Journal of Biological Chemistry. 283(44). 30079–30089. 77 indexed citations
19.
Ratner, Lee, Toni Portis, Michael D. Robek, John C. S. Harding, & William Grossman. (2000). Studies of the Immortalizing Activity of HTLV Type 1 Tax, Using an Infectious Molecular Clone and Transgenic Mice. AIDS Research and Human Retroviruses. 16(16). 1647–1651. 15 indexed citations
20.
Steagall, Wendy K., Michael D. Robek, Stephanie T. Perry, Frederick J. Fuller, & Susan Payne. (1995). Incorporation of Uracil into Viral DNA Correlates with Reduced Replication of EIAV in Macrophages. Virology. 210(2). 302–313. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eileen Foy Breakdown of academic impact, for papers by Simon P. Fletcher Breakdown of academic impact, for papers by Marco Binder Breakdown of academic impact, for papers by Rohit K. Jangra Breakdown of academic impact, for papers by Yan‐Jin Zhang Breakdown of academic impact, for papers by Meike Dittmann Breakdown of academic impact, for papers by Mary Y. Murphy Breakdown of academic impact, for papers by Franziska Lechner Breakdown of academic impact, for papers by Hiba El Hajj Breakdown of academic impact, for papers by Yinyan Sun
Rankless by CCL
2026